IRF7: Activation, regulation, modification and function

S. Ning, J. S. Pagano, Glen N Barber

Research output: Contribution to journalArticle

171 Citations (Scopus)

Abstract

Interferon regulatory factor 7 (IRF7) was originally identified in the context of Epstein-Barr virus (EBV) infection, and has since emerged as the crucial regulator of type I interferons (IFNs) against pathogenic infections, which activate IRF7 by triggering signaling cascades from pathogen recognition receptors (PRRs) that recognize pathogenic nucleic acids. Moreover, IRF7 is a multifunctional transcription factor, underscored by the fact that it is associated with EBV latency, in which IRF7 is induced as well as activated by the EBV principal oncoprotein latent membrane protein-1 (LMP1). Aberrant production of type I IFNs is associated with many types of diseases such as cancers and autoimmune disorders. Thus, tight regulation of IRF7 expression and activity is imperative in dictating appropriate type I IFN production for normal IFN-mediated physiological functions. Posttranslational modifications have important roles in regulation of IRF7 activity, exemplified by phosphorylation, which is indicative of its activation. Furthermore, mounting evidence has shed light on the importance of regulatory ubiquitination in activation of IRF7. Albeit these exciting findings have been made in the past decade since its discovery, many questions related to IRF7 remain to be addressed.

Original languageEnglish
Pages (from-to)399-414
Number of pages16
JournalGenes and Immunity
Volume12
Issue number6
DOIs
StatePublished - Sep 1 2011

Fingerprint

Interferon Regulatory Factor-7
Interferon Type I
Human Herpesvirus 4
Virus Latency
Epstein-Barr Virus Infections
Ubiquitination
Oncogene Proteins
Post Translational Protein Processing
Nucleic Acids
Interferons
Membrane Proteins
Transcription Factors
Phosphorylation

Keywords

  • EBV
  • IFN
  • IRF7
  • LMP1
  • PRR

ASJC Scopus subject areas

  • Genetics(clinical)
  • Immunology
  • Genetics

Cite this

IRF7 : Activation, regulation, modification and function. / Ning, S.; Pagano, J. S.; Barber, Glen N.

In: Genes and Immunity, Vol. 12, No. 6, 01.09.2011, p. 399-414.

Research output: Contribution to journalArticle

Ning, S. ; Pagano, J. S. ; Barber, Glen N. / IRF7 : Activation, regulation, modification and function. In: Genes and Immunity. 2011 ; Vol. 12, No. 6. pp. 399-414.
@article{33805bf3797e4832995b44ae66f65c2f,
title = "IRF7: Activation, regulation, modification and function",
abstract = "Interferon regulatory factor 7 (IRF7) was originally identified in the context of Epstein-Barr virus (EBV) infection, and has since emerged as the crucial regulator of type I interferons (IFNs) against pathogenic infections, which activate IRF7 by triggering signaling cascades from pathogen recognition receptors (PRRs) that recognize pathogenic nucleic acids. Moreover, IRF7 is a multifunctional transcription factor, underscored by the fact that it is associated with EBV latency, in which IRF7 is induced as well as activated by the EBV principal oncoprotein latent membrane protein-1 (LMP1). Aberrant production of type I IFNs is associated with many types of diseases such as cancers and autoimmune disorders. Thus, tight regulation of IRF7 expression and activity is imperative in dictating appropriate type I IFN production for normal IFN-mediated physiological functions. Posttranslational modifications have important roles in regulation of IRF7 activity, exemplified by phosphorylation, which is indicative of its activation. Furthermore, mounting evidence has shed light on the importance of regulatory ubiquitination in activation of IRF7. Albeit these exciting findings have been made in the past decade since its discovery, many questions related to IRF7 remain to be addressed.",
keywords = "EBV, IFN, IRF7, LMP1, PRR",
author = "S. Ning and Pagano, {J. S.} and Barber, {Glen N}",
year = "2011",
month = "9",
day = "1",
doi = "10.1038/gene.2011.21",
language = "English",
volume = "12",
pages = "399--414",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - IRF7

T2 - Activation, regulation, modification and function

AU - Ning, S.

AU - Pagano, J. S.

AU - Barber, Glen N

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Interferon regulatory factor 7 (IRF7) was originally identified in the context of Epstein-Barr virus (EBV) infection, and has since emerged as the crucial regulator of type I interferons (IFNs) against pathogenic infections, which activate IRF7 by triggering signaling cascades from pathogen recognition receptors (PRRs) that recognize pathogenic nucleic acids. Moreover, IRF7 is a multifunctional transcription factor, underscored by the fact that it is associated with EBV latency, in which IRF7 is induced as well as activated by the EBV principal oncoprotein latent membrane protein-1 (LMP1). Aberrant production of type I IFNs is associated with many types of diseases such as cancers and autoimmune disorders. Thus, tight regulation of IRF7 expression and activity is imperative in dictating appropriate type I IFN production for normal IFN-mediated physiological functions. Posttranslational modifications have important roles in regulation of IRF7 activity, exemplified by phosphorylation, which is indicative of its activation. Furthermore, mounting evidence has shed light on the importance of regulatory ubiquitination in activation of IRF7. Albeit these exciting findings have been made in the past decade since its discovery, many questions related to IRF7 remain to be addressed.

AB - Interferon regulatory factor 7 (IRF7) was originally identified in the context of Epstein-Barr virus (EBV) infection, and has since emerged as the crucial regulator of type I interferons (IFNs) against pathogenic infections, which activate IRF7 by triggering signaling cascades from pathogen recognition receptors (PRRs) that recognize pathogenic nucleic acids. Moreover, IRF7 is a multifunctional transcription factor, underscored by the fact that it is associated with EBV latency, in which IRF7 is induced as well as activated by the EBV principal oncoprotein latent membrane protein-1 (LMP1). Aberrant production of type I IFNs is associated with many types of diseases such as cancers and autoimmune disorders. Thus, tight regulation of IRF7 expression and activity is imperative in dictating appropriate type I IFN production for normal IFN-mediated physiological functions. Posttranslational modifications have important roles in regulation of IRF7 activity, exemplified by phosphorylation, which is indicative of its activation. Furthermore, mounting evidence has shed light on the importance of regulatory ubiquitination in activation of IRF7. Albeit these exciting findings have been made in the past decade since its discovery, many questions related to IRF7 remain to be addressed.

KW - EBV

KW - IFN

KW - IRF7

KW - LMP1

KW - PRR

UR - http://www.scopus.com/inward/record.url?scp=80052284504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052284504&partnerID=8YFLogxK

U2 - 10.1038/gene.2011.21

DO - 10.1038/gene.2011.21

M3 - Article

C2 - 21490621

AN - SCOPUS:80052284504

VL - 12

SP - 399

EP - 414

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 6

ER -